05 Dec UPDATE 3-Alexion Pharma rejects Elliott’s push for “proactive sale”
Alexion Pharmaceuticals Inc said
on Friday its board of directors had unanimously rejected hedge
fund Elliott Management’s push for a “proactive sale” process of
the entire company because it would not be in the best interest
of shareholders.
on Friday its board of directors had unanimously rejected hedge
fund Elliott Management’s push for a “proactive sale” process of
the entire company because it would not be in the best interest
of shareholders.
Sorry, the comment form is closed at this time.